ACTIVE

EVERLAM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

10,8 M €

+444.3% YoY

Revenue

75,5 M €

-1.9% YoY

Equity

7 M €

+284.0% YoY

Workforce

22,1 ETP

+16.3% YoY

What does EVERLAM do?

EVERLAM is a Private limited company incorporated in 2014. Its main activity is: Wholesale of chemical products. Its registered office is in Mechelen. It employs on average 22,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0545.756.444

Incorporation

31/01/2014

Legal form

Private limited company

Registered office

Blokhuisstraat 47 J
2800 Mechelen · FlandreSee on map

Contributed capital

12 939 374,00 €

Latest accounts

31/12/2025

Average workforce

22,1 ETP

Activities (NACE)

46751Wholesale of chemical products· main 46851Wholesale trade, except of motor vehicles and motorcycles 46900Non-specialised wholesale trade 46900Non-specialised wholesale trade 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 11 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015
Income statement
Revenue	75,5 M €	-1.9%	76,9 M €	+36.8%	56,2 M €	-19.0%	69,5 M €	+9.6%	63,4 M €	+25.0%	50,7 M €	-22.8%	65,6 M €	+10.4%	59,5 M €	-11.5%	67,2 M €	+383%	13,9 M €		–
EBITDA	12,5 M €	+898%	-1,6 M €	+65.9%	-4,6 M €	-26957%	17,1 k €	+130%	-57 k €	+84.3%	-363,9 k €	-131%	-157,3 k €	-41.0%	-111,5 k €	+94.3%	-2 M €	+58.0%	-4,7 M €	-709%	-577,9 k €
Operating result	11,8 M €	+678%	-2 M €	+59.3%	-5 M €	-941%	-483,6 k €	+81.1%	-2,6 M €	+26.8%	-3,5 M €	-7.0%	-3,3 M €	-2.9%	-3,2 M €	+37.1%	-5 M €	+26.6%	-6,9 M €	-1024%	-610,3 k €
Net result	10,8 M €	+444%	-3,1 M €	+44.5%	-5,7 M €	-727%	-684,8 k €	+75.8%	-2,8 M €	+36.4%	-4,4 M €	-6.1%	-4,2 M €	+3.4%	-4,3 M €	+30.8%	-6,3 M €	+9.9%	-6,9 M €	-997%	-633,4 k €
Balance sheet
Equity	7 M €	+284%	-3,8 M €	-471%	-666,9 k €	-113%	5 M €	-12.1%	5,7 M €	-33.2%	8,5 M €	+222%	2,6 M €	-29.2%	3,7 M €	-53.8%	8,1 M €	-43.7%	14,3 M €	+220159%	-6,5 k €
Total assets	38,7 M €	+15.1%	33,7 M €	-6.6%	36,1 M €	+22.2%	29,5 M €	+5.8%	27,9 M €	-17.0%	33,6 M €	-10.6%	37,6 M €	-4.0%	39,2 M €	-5.2%	41,3 M €	-8.8%	45,3 M €	+1082%	3,8 M €
Cash	4,8 M €	+11549%	40,9 k €	-92.0%	509,7 k €	-22.9%	660,8 k €	-21.7%	844,4 k €	-25.3%	1,1 M €	-66.0%	3,3 M €	+1206%	254,4 k €	-91.1%	2,9 M €	+348%	640,4 k €	+124%	285,8 k €
Debts	31,7 M €	-15.4%	37,5 M €	+2.0%	36,7 M €	+49.8%	24,5 M €	+10.3%	22,2 M €	-10.3%	24,8 M €	-29.1%	34,9 M €	-1.4%	35,4 M €	+8.3%	32,7 M €	+5.9%	30,9 M €	+704%	3,8 M €
Other
Workforce	22,1 ETP	+16.3%	19,0 ETP	+11.1%	17,1 ETP	-6.0%	18,2 ETP	-3.7%	18,9 ETP	-7.8%	20,5 ETP	-3.8%	21,3 ETP	-8.6%	23,3 ETP	-6.0%	24,8 ETP	+9.7%	22,6 ETP	+33.7%	16,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 7 active · 24 ended

Active mandates

Luc DE TEMMERMAN

Director · since 01 janvier 2026 · until 31 décembre 2028

Active

Antonie Van Beek

Director · since 29 mars 2024

Active

Hemal Aaron Parekh

Director · since 29 mars 2024

Active

Ian Burke

Director · since 29 mars 2024

Active

Indebom Strategies CommV

Director · since 29 mars 2024 · until 31 décembre 2025 · 0501.626.491

Represented by Luc De Temmerman

Active

Jaikumar Moorthy

Director · since 29 mars 2024

Active

New Rhein Healthcare Investors

Director · since 29 mars 2024 · 0567.570.853

Represented by Nayan Gregory Parekh

Active

Ended mandates

Indebom Strategies CommV

Director · since 29 mars 2024 · 0501.626.491

Represented by Luc De Temmerman

Ended

Antonie Van Beek

Director · since 01 juillet 2023 · until 12 juin 2030

Ended

Ian Burke

Director · since 01 juillet 2023 · until 12 juin 2030

Ended

Indebom Strategies CommV

Director · since 01 juillet 2023 · until 12 juin 2030 · 0501.626.491

Represented by Luc De Temmerman

Ended

At this address

Other companies at this address

Company	CBE no.
Everlam Holding● Active	0662.686.083
Gantrade Europe● Active	0717.995.384

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/06/2026	28/07/2025	19/07/2024	06/09/2023	05/12/2022	23/07/2021
General meeting	10/06/2026	10/07/2025	19/07/2024	30/06/2023	12/07/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	10/06/2026	11/06/2026	Dutch	PDF
Full model	31/12/2024	10/07/2025	28/07/2025	Dutch	PDF
Full model	31/12/2023	19/07/2024	19/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	06/09/2023	Dutch	PDF
Full modelCorrection	31/12/2021	12/07/2022	05/12/2022	Dutch	PDF
Full model	31/12/2021	12/07/2022	14/07/2022	Dutch	PDF
Full model	31/12/2020	18/06/2021	23/07/2021	Dutch	PDF
Full model	31/12/2019	03/07/2020	07/08/2020	Dutch	PDF
Full modelCorrection	31/12/2018	12/06/2019	12/11/2019	Dutch	PDF
Full model	31/12/2018	12/06/2019	01/07/2019	Dutch	PDF
Full model	31/12/2017	13/06/2018	09/07/2018	Dutch	PDF
Full modelCorrection	31/12/2016	14/06/2017	08/12/2017	Dutch	PDF
Full model	31/12/2016	14/06/2017	16/06/2017	Dutch	PDF
Full modelCorrection	31/12/2015	29/06/2016	03/01/2017	Dutch	PDF
Full model	31/12/2015	29/06/2016	07/07/2016	Dutch	PDF
Full model	31/12/2014	26/06/2015	02/07/2015	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 7 active · 24 ended

Active mandates

Luc DE TEMMERMAN

Director · since 01 janvier 2026 · until 31 décembre 2028

Active

Antonie Van Beek

Director · since 29 mars 2024

Active

Hemal Aaron Parekh

Director · since 29 mars 2024

Active

Ian Burke

Director · since 29 mars 2024

Active

Indebom Strategies CommV

Director · since 29 mars 2024 · until 31 décembre 2025 · 0501.626.491

Represented by Luc De Temmerman

Active

Jaikumar Moorthy

Director · since 29 mars 2024

Active

New Rhein Healthcare Investors

Director · since 29 mars 2024 · 0567.570.853

Represented by Nayan Gregory Parekh

Active

Ended mandates

Indebom Strategies CommV

Director · since 29 mars 2024 · 0501.626.491

Represented by Luc De Temmerman

Ended

Antonie Van Beek

Director · since 01 juillet 2023 · until 12 juin 2030

Ended

Ian Burke

Director · since 01 juillet 2023 · until 12 juin 2030

Ended

Indebom Strategies CommV

Director · since 01 juillet 2023 · until 12 juin 2030 · 0501.626.491

Represented by Luc De Temmerman

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates04/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/02/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/04/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/12/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other28/09/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares30/12/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Mandates28/09/2020
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202510,8 M €↑
2024
Annual accounts 2024-3,1 M €↑
2023
Annual accounts 2023-5,7 M €↓
2022
Annual accounts 2022-684,8 k €↑
2021
Annual accounts 2021-2,8 M €↑
2020
Annual accounts 2020-4,4 M €↓
2019
Annual accounts 2019-4,2 M €↑
2018
Annual accounts 2018-4,3 M €↑
2017
Annual accounts 2017-6,3 M €↑
2016
Annual accounts 2016-6,9 M €↓
2015
Annual accounts 2015-633,4 k €
31/01/2014
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

EVERLAM

Overview

What does EVERLAM do?

Trend over 11 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline